Ara
Toplam kayıt 35, listelenen: 31-35
High dose zoledronic acid increases ischemia-reperfusion damage of the liver
(Verduci Publisher, 2021)
OBJECTIVE: Zoledronic acid (ZA), a nitrogen-containing bisphosphonate, has been reported to exhibit a protective effect against cancers and prevent bone fractures. It also induces apoptosis by increasing proinflammatory ...
Plasma atherogenic index is an independent indicator of subclinical atherosclerosis in systemic lupus erythematosus
(Aves, 2017)
Objective: Systemic lupus erythematosus (SLE) is characterized by chronic inflammation. Plasma atherogenic index (PAI) is a valuable marker for the cardiovascular disease and cardiac risk. the aim of this study was to ...
Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behcet disease
(Springer Heidelberg, 2017)
Behcet's disease (BD) is a systemic vasculitis characterized by cardiovascular complications. Early diagnosis of these complications can reduce morbidity and mortality. Carotid artery intima-media thickness (cIMT) and the ...
Is increasing the dose of entecavir effective in partial virological responders?
(Dove Medical Press Ltd., 2014)
Objective: To analyze the effect of increasing Entecavir (ETV) dosage in patients with chronic hepatitis B (CHB) who partially responded to ETV after 1 year. Methods: Twenty-three hepatitis B e antigen (HBeAg)-positive and ...
Is adalimumab protective in ischemia‐reperfusion injury in lung?
(Mashhad University of Medical Sciences, 2015)
Objective(s): Increasing cytokines and reactive oxygen species (ROS) during ischemia reperfusion (I?R) leads to the lung damage. Adalimumab (Ada) is a potent tumor necrosis factor?alpha (TNF??) inhibitor agent. We aimed ...